Phase I studies of hypericin, the active compound in St. John’s Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258 - Gulick, R M; McAuliffe, V; Holden-Wiltse, J (Ann Intern Med, 1999)
et al.